The efficacy of glaucoma surgery with Glautex® drainage device
Bikbov M.M., Khusnitdinov I.I.

Ufa Scientific Research Institute of Eye Diseases

Aim. To assess early and long-term outcomes of Glautex® drainage device for glaucoma surgery.
Patients and methods. Glaucoma surgery with Glautex® drainage device was performed in 139 patients (148 eyes) aged 25-86 years (mean age 65.79±0.86 years). Prior glaucoma surgery was performed in 56.1% of cases. Mean preoperative IOP was 39.8 ± 0.79 mm Hg. Surgical techniques and ophthalmic examinations were described earlier. Medical examination was performed at days 1-8 and after 1, 3, 6, 12, and 24 months.
Results. After glaucoma surgery with Glautex® drainage device, IOP decreased by 70.3% as compared with the baseline (χ2 = 390.45760). Absolute and relative IOP-lowering efficacy was 74.3% (110/148) and 83.1% (123/148) after 1 year; 70.2% (104/148) and 79.7% (118/148) after 2 years; and 68.2% (101/148) and 76.3% (113/148) after 3 years. In 23.6% of cases (35/148), glaucoma surgery with Glautex® drainage device did not provide IOP reduction.
Conclusions. IOP-lowering efficacy of glaucoma surgery with Glautex® drainage device depends on glaucoma type. Up to 3 years of the follow-up, IOP-lowering efficacy of glaucoma surgery with Glautex® drainage device is 85.5% for POAG, 83.3% for pseudophakic glaucoma, 39.1% for neovascular glaucoma, and 66.4% for uveitic glaucoma.

Key words: Glautex® drainage device, drainage surgery, refractory glaucoma.
For citation: Bikbov M.M., Khusnitdinov I.I. The efficacy of glaucoma surgery with Glautex® drainage device // RMJ. Clinical ophthalmology. 2017. № 2. P. 82–85.